X-ray techniques have been used for decades by authorities to prevent crime and keep people safe. Perhaps their most well-known use is for the detection of dangerous and banned items or substances, ...

Particle size analysis is crucial to quality control and product development in a number of key industries including aerosols, construction, food and beverage, paint and coatings, and pharmaceuticals.

Definition: X-Ray Diffraction (XRD) is a powerful analytical technique used to characterize the atomic and molecular structure of a crystal. By measuring the angles and intensities of diffracted beams ...

Developing an effective and robust system for deepening our understanding of the characteristics of the tissue, structure, mechanical properties and organization of bone at the level of the nanoscale, ...

Coherent X-ray Diffraction Imaging (CXDI) is a transformative, non-destructive technique that leverages the interference patterns produced by coherent X-ray beams to reconstruct high-resolution, ...

In this session the details of XRD experiment design will be discussed with topics such as; understanding what will be determined from the sample, sample preparation, sample mounting, and details of ...

The Materials Research X-Ray Diffraction (XRD) Facility at the University of Colorado Boulder provides cutting-edge capabilities for probing the structures of materials such as polymers, biological ...

Polymer materials are employed in a huge array of applications across the various facets of contemporary society, from packaging materials to aerospace engineering. Virtually every application demands ...

In this article, we explore how X-ray diffraction, also known as XRD, can be used to analyze thin films and the benefits of using this technique. Many materials are now processed in the form of thin ...

X-ray diffraction (XRD) is a powerful non-destructive analytical technique used to evaluate crystalline materials and determine their structural properties. As one of the most widely used ...

Back in 2010, crystallographer Tim Gruene heard a scientist from drugmaker Novartis say something that stuck with him. The pharmaceutical giant had amassed a collection of around 2 million small ...